Results 71 to 80 of about 45,456 (232)
How Do I Manage Refractory Invasive Pulmonary Aspergillosis. [PDF]
BACKGROUND Invasive aspergillosis is associated with significant morbidity and mortality in patients with hematologic malignancies and hematopoietic cell transplant recipients.
Nguyen, M Hong +3 more
core +1 more source
American Journal of Hematology, Volume 101, Issue 9, Page 2258-2268, September 2026.ABSTRACT Quizartinib is a tyrosine kinase inhibitor with single agent activity in patients with relapsed or refractory (R/R) acute myeloid leukemia (AML) and has demonstrated efficacy in first‐line therapy when combined with intensive chemotherapy in both FLT3 ITD‐negative and positive AML.
Teresa Bernal +29 more
wiley +1 more source
IatreiaIntroduction: Aspergillosis is an opportunistic mycosis with significant impact on immunocompromised patients; available data in Paraguay are scarce.
Aguilar-Fernández, Gustavo +4 more
doaj +1 more source
Isavuconazole in the treatment of invasive aspergillosis and mucormycosis infections [PDF]
, 2016 Monica A Donnelley,1,2 Elizabeth S Zhu,1 George R Thompson 3rd3 1Department of Inpatient Pharmacy, University of California – Davis, Sacramento, 2Department of Clinical Sciences, Touro University College of Pharmacy, Vallejo, 3Department of ...
Zhu ES, Thompson GR 3rd, Donnelley MA
core
ACR Open Rheumatology, Volume 8, Issue 8, August 2026.Objective Sjögren's disease (SjD) is a chronic autoimmune disease with a complex etiology, where pathogens may influence disease development or progression. Although SjD is not communicable, environmental and endemic pathogen exposures may influence its onset or progression.
Swetha K. Shankar +3 more
wiley +1 more source
American Journal of Hematology, Volume 101, Issue 8, Page 1818-1827, August 2026.ABSTRACT CD19‐directed chimeric antigen receptor (CAR) T‐cell therapy has transformed outcomes for patients with relapsed or refractory (r/r) mantle cell lymphoma (MCL), yet more than 40% relapse within one year. Early identification of patients at risk for progression could inform post CAR‐T surveillance and consolidation strategies.
Snegha Ananth +12 more
wiley +1 more source
Clinical Case Reports, 2022 Aspergillosis superinfections have been reported as acute complications of COVID‐19. We report a rare case of combined chronic necrotizing pulmonary aspergillosis, aspergilloma, and fibrosing aspergillosis in a 31‐year‐old woman with a history of COVID ...
Zamelina Angela Razafindrasoa +9 more
doaj +1 more source
American Journal of Medical Genetics Part A, Volume 200, Issue 8, Page 1850-1855, August 2026.ABSTRACT Griscelli Syndrome Type 2 (GS2) is a rare autosomal recessive disorder caused by pathogenic mutations in the RAB27A gene. Typically, it is characterized by cutaneous hypopigmentation, immunodeficiency, with or without neurological abnormalities secondary to hemophagocytic lymphohistiocytosis (HLH). Without treatment, GS2 often results in fatal
Dzhoy Papingi +6 more
wiley +1 more source
Haematologica, 2011 Background The study objectives were: 1) to report on invasive aspergillosis patients in a hematology department; and 2) to estimate its incidence according to the hematologic diagnosis.Design and Methods A prospective survey of invasive aspergillosis ...
Marie-Christine Nicolle +14 more
doaj +1 more source
Treatment of Aspergillosis [PDF]
Journal of Fungi, 2018 Infections caused by Aspergillus spp. remain associated with high morbidity and mortality. While mold-active antifungal prophylaxis has led to a decrease of occurrence of invasive aspergillosis (IA) in those patients most at risk for infection, breakthrough IA does occur and remains difficult to diagnose due to low sensitivities of mycological tests ...
Jeffrey D. Jenks, Martin Hoenigl
openaire +5 more sources